Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for AN2 Therapeutics (ANTX): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Market Outperform
7 analysts
Options Flow (P/C)
—
Avg Consensus PT
$5
+1.5%
Highest Price Target
$9
+69.2%
Lowest Price Target
$2
-62.4%
Short Interest
7.5%
Declining — Bullish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Guggenheim | Brad Canino— | +69.2% | $9 | Initiate | Buy |
| May 14, 2026 | Leerink Partners | Joseph Schwartz— | +69.2% | $9 | Upgrade | Market Perform→Outperform |